Skip to main content

Analysis: What are insurtechs doing in the face of the coronavirus pandemic – Part Two: Pan-European start-ups?

europe

In light of the Coronavirus pandemic, Post content director Jonathan Swift caught up with a number of insurtechs to find out what they are doing to reduce staff and client’s exposure to Covid-19, while keeping operations as business-as-usual as possible. Today in the second of a three-part series he focuses on start-ups with offices in more than one European country.

How well placed are you to trade in the event of travel restrictions/quarantine etc?

Bought By Many [UK and Sweden] founder Steven Mendel: “We deliver a very human

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Amazon on how insurers can get out of pilot purgatory

Insurers looking to move beyond proof-of-concept pilots must focus on customer problems, matching AI tools to specific tasks and establish clear guardrails, according to Terry Buechner, global head of insurance core system modernisation at Amazon Web Services.

Guidewire pays £1.2bn for Hyperexponential

Guidewire is set to buy Hyperexponential for $1.7bn (£1.27bn), with $400m (£300.05m) more payable if recurring revenue targets are hit, as it looks to ‘define’ the use of artificial intelligence in underwriting.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here